wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q39695611-FD1E39C1-3ED8-449F-AB77-5907613E34EC
Q39695611-FD1E39C1-3ED8-449F-AB77-5907613E34EC
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39695611-FD1E39C1-3ED8-449F-AB77-5907613E34EC
Metronomic gemcitabine suppresses tumour growth, improves perfusion, and reduces hypoxia in human pancreatic ductal adenocarcinoma
P2860
Q39695611-FD1E39C1-3ED8-449F-AB77-5907613E34EC
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39695611-FD1E39C1-3ED8-449F-AB77-5907613E34EC
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
e85944169b34b34cb2f348e24a4408ecd87c620f
P2860
Phase II clinical trial results involving treatment with low-dose daily oral cyclophosphamide, weekly vinblastine, and rofecoxib in patients with advanced solid tumors.